Azithromycin Dosing for Pediatric Patients
For pediatric patients, azithromycin dosing is weight-based and varies by age and indication, with infants under 6 months requiring 10 mg/kg/day for 5 days, while older children typically receive 10 mg/kg on day 1 followed by 5 mg/kg/day on days 2-5. 1
Standard Oral Dosing by Age and Indication
Infants Under 6 Months
- Dose: 10 mg/kg per day for 5 consecutive days 2
- This simplified regimen is preferred for this age group, particularly for pertussis treatment and prophylaxis
- Critical safety note: Infants under 1 month receiving macrolides should be monitored for infantile hypertrophic pyloric stenosis (IHPS) and other serious adverse events 2
Infants and Children 6 Months and Older
For most respiratory infections (otitis media, community-acquired pneumonia):
- Day 1: 10 mg/kg (maximum 500 mg)
- Days 2-5: 5 mg/kg per day (maximum 250 mg per day) 1
Alternative 3-day regimen (otitis media, acute bacterial sinusitis):
- 10 mg/kg once daily for 3 days 1
Single-dose regimen (otitis media only):
- 30 mg/kg as a single dose (maximum 1500 mg) 1
Pharyngitis/Tonsillitis (age ≥2 years):
- 12 mg/kg once daily for 5 days (maximum 500 mg per day) 1
- This higher dose is necessary because standard dosing showed more recurrence compared to penicillin 3
Specific Weight-Based Examples (5-Day Regimen)
| Weight | Day 1 | Days 2-5 | Total Course |
|---|---|---|---|
| 5 kg (11 lbs) | 2.5 mL | 1.25 mL | 150 mg |
| 10 kg (22 lbs) | 5 mL | 2.5 mL | 300 mg |
| 20 kg (44 lbs) | 5 mL* | 2.5 mL* | 600 mg |
| 30 kg (66 lbs) | 7.5 mL | 3.75 mL | 900 mg |
| ≥50 kg (≥110 lbs) | 12.5 mL | 6.25 mL | 1500 mg |
*Using 200 mg/5 mL suspension 1
Intravenous Dosing
While IV azithromycin is used off-label in children, research supports:
- Loading dose: 15 mg/kg
- Maintenance: 10 mg/kg daily 4
This achieves appropriate pharmacokinetic targets in children with community-acquired pneumonia.
Special Populations and Adjustments
Hepatic Impairment
Azithromycin should be prescribed with caution in patients with impaired hepatic function 2. For children with elevated ALT (>40 U/L), reduce the dose by approximately 15% to achieve comparable drug exposure 4. The pharmacokinetics show a 24% decrease in clearance when ALT exceeds 40 U/L 4.
Renal Impairment
- No dose adjustment needed for mild to moderate renal impairment (GFR 10-80 mL/min) 1
- Exercise caution in severe renal impairment (GFR <10 mL/min) as drug exposure increases by 35% 1
Simplified Field Dosing (for mass distribution programs)
For resource-limited settings where weight measurement is impractical:
Age-based approach (2-tier):
- 1-2 months: 80 mg (2 mL)
- 3-11 months: 160 mg (4 mL)
- This achieves 89-93% accuracy within therapeutic tolerance limits 5
Age-based approach (3-tier, higher accuracy):
- 1-2 months: 80 mg (2 mL)
- 3-4 months: 120 mg (3 mL)
- 5-11 months: 160 mg (4 mL)
- This achieves 93-94% accuracy 5
Safety Considerations
Common Adverse Events
Adverse events occur in approximately 8.7% of pediatric patients, predominantly mild-to-moderate gastrointestinal symptoms (5.3%) including abdominal discomfort, diarrhea, nausea, and vomiting 6. Treatment discontinuation due to adverse events occurs in only 1.3% of cases 6.
Higher Dose Regimens
The 30 mg/kg single dose and 20 mg/kg/day for 3 days regimens are well-tolerated but associated with slightly more adverse effects than standard dosing 7.
Critical Drug Interactions
- Avoid concurrent aluminum- or magnesium-containing antacids as they reduce azithromycin absorption 2
- Monitor patients receiving drugs metabolized by cytochrome P450 (digoxin, triazolam, ergot alkaloids) 2
Contraindications
- History of hypersensitivity to any macrolide agent 2
- Do not use with astemizole, cisapride, pimozide, or terfenadine (when using erythromycin or clarithromycin) 2
Administration Pearls
- Azithromycin can be taken with or without food 1
- The oral suspension is well-tolerated with agreeable taste and color for children 7
- For patients who vomit within 30 minutes of a 30 mg/kg single dose, re-dosing at the same total dose has been done in clinical studies, though safety data are limited 1
- Treatment duration for most infections is 3-5 days, significantly shorter than comparator antibiotics 3